442 Results
Sort By:
Published on July 2, 2018
WuXi NextCODE today launched what it said was the world's first blockchain-enabled health databank, LifeCODE.ai, and an app designed to enable users to access the databank from their smartphones. LifeCODE.ai is designed to solve the legality and effectiveness of large-scale health data collection by applying blockchain technology, while protecting individual…
Published on June 16, 2018
Researchers say they have mapped the gene expression of each individual brain cell during aging in the fruit fly. Their study (“A Single-Cell Transcriptome Atlas of the Aging Drosophila Brain”), published in Cell, could lead to new insights on the workings of the brain as it ages, according to the…
Published on June 6, 2018
Microbiotica said today it will use its precision metagenomics microbiome platform in an up-to-$534 million-plus multi-year partnership with Genentech, a member of the Roche Group, to discover, develop and commercialize microbiome-based biomarkers and therapies for inflammatory bowel disease (IBD). Microbiotica, a Wellcome Trust Sanger Institute spinout, said the platform allows…
Published on June 2, 2018
Qiagen has announced a partnership with aritificial intelligence (AI) genomics company Freenome to accelerate the development and commercialization of next-generation sequencing (NGS) tests to enable precision medicine in cancer treatment. The alliance is part of internal initiatives and partnerships that Qiagen is creating to reach patients more quickly with NGS…
Published on May 22, 2018
Genomenon has announced it will partner with Veritas Genetics to develop a next-generation literature prioritization engine the companies said will further scale the global adoption of whole-genome sequencing by reducing the time and cost of variant interpretation. The engine will incorporate proprietary genomic language processing (GLP), machine learning (ML), and…
Published on May 11, 2018
Machine learning and artificial intelligence (AI) are prominent buzzwords when the topic of precision medicine comes up, but like many emerging technologies with the potential to make a significant impact, it can be difficult sometimes to separate the hype from the real-world impact. AI entered that breathless, overhyped territory last…
Published on April 23, 2018
Precision Therapeutics said today it agreed to acquire all shares of Helomics, up from its current 25% stake, in a deal designed to catapult the buyer into leadership in precision oncology. Minneapolis-based Precision Therapeutics has signed a letter of intent to buy the remaining Helomics shares it did not currently…
Published on April 16, 2018
The Lustgarten Foundation and Stand Up To Cancer (SU2C) said they will commit an initial $25 million into a new partnership aimed at generating further research into, and ultimately new treatments for, pancreatic cancer. The Pancreatic Cancer Collective said it aims to innovate and accelerate research into the disease. Its…
Published on April 10, 2018
Wave Life Sciences will use Deep Genomics’ machine learning-driven biomedical platform to discover novel therapies for treating genetic neuromuscular disorders, the companies said today, through a collaboration whose value was not disclosed. Under the collaboration, the companies have agreed to analyze and test oligonucleotides against potential therapeutic targets within multiple…
Published on April 3, 2018
Genomenon said today it will partner with Veritas, The Genome Company, to develop a next-generation literature prioritization engine through a partnership whose value was not disclosed. The companies have committed to creating an engine they said will further scale the global adoption of whole genome sequencing by reducing the time…
Published on March 23, 2018
Molecular diagnostics company Biodesix has entered into a biomarker research collaboration with Checkmate Pharmaceuticals, a Cambridge, MA-based biopharmaceutical company focused on developing novel approaches to cancer immunotherapy. The collaboration will leverage MALDI-TOF mass spectrometry analysis of the circulating proteome of advanced melanoma patients treated with Checkmate’s candidate CMP-001 in combination…
Published on March 13, 2018
The American Heart Association (AHA) and the Duke Clinical Research Institute (DCRI) have announced a strategic alliance that will leverage the artificial intelligence and Big Data to aid in the prediction, prevention and treatment of cardiovascular diseases. The alliance will see the DCRI, under the direction of Michael Pencina, Ph.D.,…
Published on February 21, 2018
Cognoa said today that its artificial intelligence (AI)-based software platform for behavioral health conditions has received the FDA’s Class II diagnostic medical device designation for autism. The designation, Cognoa said, will expand its ability to offer its solution to enterprise customers, healthcare payers, and directly to clinicians in primary care…
Published on February 6, 2018
Swiss artificial intelligence health company Sophia Genetics announced the launch of what it calls the world’s first capture-based myeloid clinical solution to receive the CE-IVD mark. The Myeloid Solution comprehensively covers genes associated with hematological disorders to provides clinicians with rapid and precisely analyzes their patients’ DNA. The test includes…
Published on December 15, 2017
Berg said it plans to develop novel biomarker strategies for Alzheimer's disease and other neurodegenerative disorders through a research partnership with Massachusetts General Hospital, and Brigham and Women's Hospital (BWH). Under the collaboration, whose value was not disclosed, Mass General and BWH will provide Berg with access to a longitudinal…